Source: phys.orgDevelopment of vaccines against SARS-CoV-2 has been rapid, but the rise of variants forces scientists to frequently modify treatments. Ideally, therapies would target mutation-resistant viral proteins, but this has proven difficult. Researchers reporting in ACS Central Science, however, have now developed a system that directly targets and degrades the viral RNA genome, reducing infection in mice. The method could be adapted to fight off many viruses, as well as treat various diseases.

Source: The Nation April 26, 2023 19:03 UTC